Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Basal Cell Nevus Syndrome”

52 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 52 results

Not applicableEnded earlyNCT04688749
What this trial is testing

Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage

Who this might be right for
Melanoma (Skin)Basal Cell CarcinomaSquamous Cell Carcinoma+5 more
Aristotle University Of Thessaloniki 50
Testing effectiveness (Phase 2)Study completedNCT00957229
What this trial is testing

To Determine The Efficacy and Safety of GDC-0449 in Patients With Basal Cell Nevus Syndrome (BCNS)

Who this might be right for
Basal Cell Nevus SyndromeGorlin Syndrome
UCSF Benioff Children's Hospital Oakland 41
Testing effectiveness (Phase 2)Study completedNCT00586040
What this trial is testing

Photochemical Tissue Bonding

Who this might be right for
Basal Cell CarcinomaSquamous Cell CarcinomaAtypical Nevus
Massachusetts General Hospital 40
Not applicableStudy completedNCT00025012
What this trial is testing

Isotretinoin in Preventing Skin Cancer

Who this might be right for
Melanoma (Skin)Non-melanomatous Skin Cancer
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Early research (Phase 1)Study completedNCT03467789
What this trial is testing

Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma

Who this might be right for
Basal Cell CarcinomaBasal Cell Nevus Syndrome
Case Comprehensive Cancer Center 37
Not applicableStudy completedNCT00540566
What this trial is testing

Optical Biopsy of Human Skin in Conjunction With Laser Treatment

Who this might be right for
Malignant MelanomaMerkel Cell CarcinomaBasal Cell Carcinoma+12 more
University of California, Irvine 113
Not applicableStudy completedNCT01014819
What this trial is testing

A Clinical Trial of Dermacorder for Detecting Malignant Skin Lesions

Who this might be right for
Basal Cell Carcinoma
UCSF Benioff Children's Hospital Oakland 30
Testing effectiveness (Phase 2)Looking for participantsNCT07285044
What this trial is testing

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

Who this might be right for
AmyloidosisBasal Cell CarcinomaBiliary Tract Carcinoma+26 more
Mayo Clinic 27
Not applicableStudy completedNCT02100371
What this trial is testing

Study of BMS-833923 in Two Specific Patients With Basal Cell Nevus Syndrome

Who this might be right for
Basal Cell Nevus Syndrome
University Health Network, Toronto 2
Large-scale testing (Phase 3)Ended earlyNCT04308395
What this trial is testing

Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)

Who this might be right for
Basal Cell Nevus Syndrome
Sol-Gel Technologies, Ltd. 108
Not applicableEnrolling By InvitationNCT06330324
What this trial is testing

Reproductive Options in Inherited Skin Diseases

Who this might be right for
IchthyosisPalmoplantar KeratosesEpidermolysis Bullosa+7 more
Maastricht University Medical Center 650
Testing effectiveness (Phase 2)Study completedNCT01350115
What this trial is testing

Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)

Who this might be right for
Basal Cell CarcinomaGorlin SyndromeNevoid Basal Cell Carcinoma Syndrome
Novartis Pharmaceuticals 10
Testing effectiveness (Phase 2)Temporarily pausedNCT03208296
What this trial is testing

Study of ASN-002 to Treat Basal Cell Carcinomas (BCCs) in Individuals With Basal Cell Nevus Syndrome (BCNS)

Who this might be right for
Basal Cell Carcinoma in Basal Cell Nevus Syndrome
Ascend Biopharmaceuticals Ltd 24
Testing effectiveness (Phase 2)Study completedNCT02017964
What this trial is testing

Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma

Who this might be right for
Desmoplastic/Nodular MedulloblastomaMedulloblastomaMedulloblastoma With Extensive Nodularity+1 more
Children's Oncology Group 26
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT04893486
What this trial is testing

CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome

Who this might be right for
BCCs in Gorlin Syndrome Patients
Palvella Therapeutics, Inc. 73
Not applicableStudy completedNCT00005660
What this trial is testing

The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases

Who this might be right for
Basal Cell CarcinomaKeratosis Palmaris et PlantarisPsoriasis
National Cancer Institute (NCI) 130
Not applicableStudy completedNCT02157623
What this trial is testing

Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome

Who this might be right for
Basal Cell Nevus Syndrome
Edward Maytin, MD, PhD 3
Testing effectiveness (Phase 2)Study completedNCT02762084
What this trial is testing

Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas in Gorlin Syndrome Patients

Who this might be right for
Basal Cell Nevus Syndrome
PellePharm, Inc. 17
Testing effectiveness (Phase 2)Study completedNCT02828111
What this trial is testing

Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas

Who this might be right for
Basal Cell Carcinomas
PellePharm, Inc. 36
Load More Results